234 related articles for article (PubMed ID: 23629521)
1. Physical activity, tumor PTGS2 expression, and survival in patients with colorectal cancer.
Yamauchi M; Lochhead P; Imamura Y; Kuchiba A; Liao X; Qian ZR; Nishihara R; Morikawa T; Shima K; Wu K; Giovannucci E; Meyerhardt JA; Fuchs CS; Chan AT; Ogino S
Cancer Epidemiol Biomarkers Prev; 2013 Jun; 22(6):1142-52. PubMed ID: 23629521
[TBL] [Abstract][Full Text] [Related]
2. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial.
Kosumi K; Hamada T; Zhang S; Liu L; da Silva A; Koh H; Twombly TS; Mima K; Morikawa T; Song M; Nowak JA; Nishihara R; Saltz LB; Niedzwiecki D; Ou FS; Zemla T; Mayer RJ; Baba H; Ng K; Giannakis M; Zhang X; Wu K; Giovannucci EL; Chan AT; Fuchs CS; Meyerhardt JA; Ogino S
Eur J Cancer; 2019 Apr; 111():82-93. PubMed ID: 30826660
[TBL] [Abstract][Full Text] [Related]
3. Association of CTNNB1 (beta-catenin) alterations, body mass index, and physical activity with survival in patients with colorectal cancer.
Morikawa T; Kuchiba A; Yamauchi M; Meyerhardt JA; Shima K; Nosho K; Chan AT; Giovannucci E; Fuchs CS; Ogino S
JAMA; 2011 Apr; 305(16):1685-94. PubMed ID: 21521850
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA MIR21 (miR-21) and PTGS2 Expression in Colorectal Cancer and Patient Survival.
Mima K; Nishihara R; Yang J; Dou R; Masugi Y; Shi Y; da Silva A; Cao Y; Song M; Nowak J; Gu M; Li W; Morikawa T; Zhang X; Wu K; Baba H; Giovannucci EL; Meyerhardt JA; Chan AT; Fuchs CS; Qian ZR; Ogino S
Clin Cancer Res; 2016 Aug; 22(15):3841-8. PubMed ID: 26957558
[TBL] [Abstract][Full Text] [Related]
5. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer.
Hanyuda A; Kim SA; Martinez-Fernandez A; Qian ZR; Yamauchi M; Nishihara R; Morikawa T; Liao X; Inamura K; Mima K; Cao Y; Zhang X; Wu K; Chan AT; Giovannucci EL; Meyerhardt JA; Fuchs CS; Shivdasani RA; Ogino S
Ann Surg Oncol; 2016 Mar; 23(3):908-17. PubMed ID: 26577117
[TBL] [Abstract][Full Text] [Related]
6. CDK8 expression in 470 colorectal cancers in relation to beta-catenin activation, other molecular alterations and patient survival.
Firestein R; Shima K; Nosho K; Irahara N; Baba Y; Bojarski E; Giovannucci EL; Hahn WC; Fuchs CS; Ogino S
Int J Cancer; 2010 Jun; 126(12):2863-73. PubMed ID: 19790197
[TBL] [Abstract][Full Text] [Related]
7. PTGER2 overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Baba Y; Nosho K; Shima K; Goessling W; Chan AT; Ng K; Chan JA; Giovannucci EL; Fuchs CS; Ogino S
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):822-31. PubMed ID: 20200425
[TBL] [Abstract][Full Text] [Related]
8. Association Between Plasma Levels of Macrophage Inhibitory Cytokine-1 Before Diagnosis of Colorectal Cancer and Mortality.
Mehta RS; Chong DQ; Song M; Meyerhardt JA; Ng K; Nishihara R; Qian Z; Morikawa T; Wu K; Giovannucci EL; Fuchs CS; Ogino S; Chan AT
Gastroenterology; 2015 Sep; 149(3):614-22. PubMed ID: 26026393
[TBL] [Abstract][Full Text] [Related]
9. Prospective analysis of body mass index, physical activity, and colorectal cancer risk associated with β-catenin (CTNNB1) status.
Morikawa T; Kuchiba A; Lochhead P; Nishihara R; Yamauchi M; Imamura Y; Liao X; Qian ZR; Ng K; Chan AT; Meyerhardt JA; Giovannucci E; Fuchs CS; Ogino S
Cancer Res; 2013 Mar; 73(5):1600-10. PubMed ID: 23442321
[TBL] [Abstract][Full Text] [Related]
10. Associations of beta-catenin alterations and MSI screening status with expression of key cell cycle regulating proteins and survival from colorectal cancer.
Wangefjord S; Brändstedt J; Lindquist KE; Nodin B; Jirström K; Eberhard J
Diagn Pathol; 2013 Jan; 8():10. PubMed ID: 23337059
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D status after colorectal cancer diagnosis and patient survival according to immune response to tumour.
Hamada T; Liu L; Nowak JA; Mima K; Cao Y; Ng K; Twombly TS; Song M; Jung S; Dou R; Masugi Y; Kosumi K; Shi Y; da Silva A; Gu M; Li W; Keum N; Wu K; Nosho K; Inamura K; Meyerhardt JA; Nevo D; Wang M; Giannakis M; Chan AT; Giovannucci EL; Fuchs CS; Nishihara R; Zhang X; Ogino S
Eur J Cancer; 2018 Nov; 103():98-107. PubMed ID: 30219720
[TBL] [Abstract][Full Text] [Related]
12. Regular Aspirin Use Associates With Lower Risk of Colorectal Cancers With Low Numbers of Tumor-Infiltrating Lymphocytes.
Cao Y; Nishihara R; Qian ZR; Song M; Mima K; Inamura K; Nowak JA; Drew DA; Lochhead P; Nosho K; Morikawa T; Zhang X; Wu K; Wang M; Garrett WS; Giovannucci EL; Fuchs CS; Chan AT; Ogino S
Gastroenterology; 2016 Nov; 151(5):879-892.e4. PubMed ID: 27475305
[TBL] [Abstract][Full Text] [Related]
13. Tumor expression of calcium sensing receptor and colorectal cancer survival: Results from the nurses' health study and health professionals follow-up study.
Momen-Heravi F; Masugi Y; Qian ZR; Nishihara R; Liu L; Smith-Warner SA; Keum N; Zhang L; Tchrakian N; Nowak JA; Yang W; Ma Y; Bowden M; da Silva A; Wang M; Fuchs CS; Meyerhardt JA; Ng K; Wu K; Giovannucci E; Ogino S; Zhang X
Int J Cancer; 2017 Dec; 141(12):2471-2479. PubMed ID: 28856682
[TBL] [Abstract][Full Text] [Related]
14. Tumor TP53 expression status, body mass index and prognosis in colorectal cancer.
Morikawa T; Kuchiba A; Liao X; Imamura Y; Yamauchi M; Qian ZR; Nishihara R; Sato K; Meyerhardt JA; Fuchs CS; Ogino S
Int J Cancer; 2012 Sep; 131(5):1169-78. PubMed ID: 22038927
[TBL] [Abstract][Full Text] [Related]
15. Aspirin Use and Colorectal Cancer Survival According to Tumor CD274 (Programmed Cell Death 1 Ligand 1) Expression Status.
Hamada T; Cao Y; Qian ZR; Masugi Y; Nowak JA; Yang J; Song M; Mima K; Kosumi K; Liu L; Shi Y; da Silva A; Gu M; Li W; Keum N; Zhang X; Wu K; Meyerhardt JA; Giovannucci EL; Giannakis M; Rodig SJ; Freeman GJ; Nevo D; Wang M; Chan AT; Fuchs CS; Nishihara R; Ogino S
J Clin Oncol; 2017 Jun; 35(16):1836-1844. PubMed ID: 28406723
[TBL] [Abstract][Full Text] [Related]
16. Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells.
Koh H; Hamada T; Song M; Liu L; Cao Y; Nowak JA; da Silva A; Twombly T; Morikawa T; Kim SA; Masugi Y; Kosumi K; Shi Y; Gu M; Li W; Du C; Chen Y; Li W; Liu H; Li C; Wu K; Nosho K; Inamura K; Hanyuda A; Zhang X; Giannakis M; Chan AT; Fuchs CS; Nishihara R; Meyerhardt JA; Ogino S
JNCI Cancer Spectr; 2018 Oct; 2(4):pky058. PubMed ID: 31276098
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer expression of peroxisome proliferator-activated receptor gamma (PPARG, PPARgamma) is associated with good prognosis.
Ogino S; Shima K; Baba Y; Nosho K; Irahara N; Kure S; Chen L; Toyoda S; Kirkner GJ; Wang YL; Giovannucci EL; Fuchs CS
Gastroenterology; 2009 Apr; 136(4):1242-50. PubMed ID: 19186181
[TBL] [Abstract][Full Text] [Related]
18. Lack of Absent in Melanoma 2 (AIM2) expression in tumor cells is closely associated with poor survival in colorectal cancer patients.
Dihlmann S; Tao S; Echterdiek F; Herpel E; Jansen L; Chang-Claude J; Brenner H; Hoffmeister M; Kloor M
Int J Cancer; 2014 Nov; 135(10):2387-96. PubMed ID: 24729378
[TBL] [Abstract][Full Text] [Related]
19. Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.
Goos JA; Hiemstra AC; Coupé VM; Diosdado B; Kooijman W; Delis-Van Diemen PM; Karga C; Beliën JA; Menke-van der Houven van Oordt CW; Geldof AA; Meijer GA; Hoekstra OS; Fijneman RJ; ;
Br J Cancer; 2014 Aug; 111(4):749-55. PubMed ID: 24983372
[TBL] [Abstract][Full Text] [Related]
20. Aspirin use and survival after diagnosis of colorectal cancer.
Chan AT; Ogino S; Fuchs CS
JAMA; 2009 Aug; 302(6):649-58. PubMed ID: 19671906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
